Ventilator study aims to personalize breathing support for ARDS patients
NCT ID NCT05578742
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at how two different levels of breathing support (called PEEP) affect lung function in patients with a severe lung condition called ARDS. The researchers want to see if the response differs based on the patient's lung stiffness. They will use a special imaging technique to measure how well air and blood flow match in the lungs. The goal is to learn how to personalize ventilator settings for better outcomes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 50 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Feb 2024
- Expected to finish
-
Sep 2026
An estimate. End dates often move.
- Lead sponsor
-
A government agency
The lead sponsor is a government body.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion criteria: * intubated patients with moderate and severe ARDS (Berlin definition, PaO2/FiO2 ≤200 mmHg at PEEP 5 cmH2O) * undergoing deep sedation * on controlled mechanical ventilation * between 24 hours and 5 days after intubation. Exclusion criteria: * age \<18 years old; pregnancy * patient undergoing legal protection * contra-indications to EIT (e. g. severe chest trauma or wounds) * pneumothorax; patient undergoing ECMO * patient with BMI ≥35 kg/m2 * hemodynamic instability with MAP \<60 mmHg despite vasopressors.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ARDS are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Angers Hospital
RECRUITINGAngers, Maine et Loire, 49933, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Is thicker blood a hidden player in ARDS?
- Can a wrist sensor cut the dose of ICU muscle relaxants?
- Stem cell infusion may help severely ill COVID-19 patients breathe
- Breathing new life: tailored ventilation for ARDS patients
- Blood test may spot lung risk in brain injury patients
- Can a smartphone app heal the hidden wounds of the ICU?